Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 34

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

338

HTML

2805

Figures (1-3)

225

Sum=3368

Sep 14, 2007 (publication date) through Nov 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Sep 14, 2007; 13(34): 4615-4619
Published online Sep 14, 2007. doi: 10.3748/wjg.v13.i34.4615

Figure 1 Tumor growth suppression curve: tumor volumes of the rAAV-KAL group versus the rAAV-GFP group on the indicated days.

Figure 2 Representative photographs of a tumor at 21 d for mice injected with rAAV-GFP and rAAV-KAL intratumorally.

Figure 3 Evaluation of microvessel density at 21 d after intratumor injection of rAAV-GFP (A) and rAAV-KAL (B) (×200).

Citation: Diao Y, Ma J, Xiao WD, Luo J, Li XY, Chu KW, Fung PW, Habib N, Farzaneh F, Xu RA. Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin. World J Gastroenterol 2007; 13(34): 4615-4619
URL: https://www.wjgnet.com/1007-9327/full/v13/i34/4615.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i34.4615